TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology
The Dermatology Digest
DECEMBER 20, 2023
Secondary measures of efficacy, as well as safety and pharmacokinetics, will also be assessed. Head of the SAB, Is a Professor of Dermatology with Penn State Health Hershey Medical Center, and Penn State College of Medicine. The primary efficacy endpoint is the percent change in EASI over 4 weeks. Billingsley, MD.,
Let's personalize your content